Leptin signaling in adipose tissue: Role in lipid accumulation and weight gain

Circulation Research

Volumn 111, Issue 5, 2012, Pages 599-603

  Singh, Prachi ^a   Peterson, Timothy E ^a   Sert Kuniyoshi, Fatima H ^a   Glenn, Jason A ^a   Davison, Diane E ^a   Romero Corral, Abel ^a   Pusalavidyasagar, Snigdha ^a   Jensen, Michael D ^a   Somers, Virend K ^a  

^a MAYO CLINIC   (United States)

Author keywords

caveolin 1; impaired signaling; leptin; lipid accumulation; weight gain

Indexed keywords

CAVEOLIN 1; FATTY ACID SYNTHASE; LEPTIN; PERILIPIN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BIOGENESIS; BODY WEIGHT; FEMALE; HUMAN; HUMAN CELL CULTURE; HUMAN EXPERIMENT; LIPID METABOLISM; LIPID STORAGE; MALE; NORMAL HUMAN; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT GAIN;

ADIPOCYTES, WHITE; ADIPOSE TISSUE, WHITE; ADULT; CAVEOLIN 1; CELLS, CULTURED; FEEDBACK, PHYSIOLOGICAL; FEMALE; HUMANS; HYPERPHAGIA; LEPTIN; LIPID METABOLISM; LONGITUDINAL STUDIES; MALE; SIGNAL TRANSDUCTION; STEM CELLS; WEIGHT GAIN; YOUNG ADULT;

EID: 84865506076     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.273656     Document Type: Article

References (16)

1. Sweeney G. Cardiovascular effects of leptin. Nature reviews. 2010;7:22-29.
2. Mark AL, Correia ML, Rahmouni K, Haynes WG. Loss of leptin actions in obesity: Two concepts with cardiovascular implications. Clin Exp Hypertens. 2004;26:629-636. (Pubitemid 40129751)
3. Devaraj S, Torok N. Leptin: The missing link between obesity and heart disease? Atherosclerosis. 2011;217:322-323.
4. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52:1201-1210.
5. DeClercq V, Taylor C, Zahradka P. Adipose tissue: The link between obesity and cardiovascular disease. Cardiovasc Hematol Dis Drug Targets. 2008;8:228-237.
6. Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, Chrousos GP, Scherbaum WA. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes. 2000;49: 532-538. (Pubitemid 30183740)
7. Ceddia RB. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: Implications for glucose and fatty acids homeostasis. Int J Obesity. 2005;29:1175-1183. (Pubitemid 43080295)
8. Catalan V, Gomez-Ambrosi J, Rodriguez A, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Fruhbeck G. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin Endocrinol. 2008;68:213-219.
9. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem. 2002;277:8635-8647. (Pubitemid 34968330)
10. Wang MY, Orci L, Ravazzola M, Unger RH. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: Implications for treatment of human obesity. Proc Natl Acad Sci USA. 2005;102:18011-18016. (Pubitemid 41798493)
11. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: A roadmap to lipotoxicity. Trends Endocrinol Metab. 2010;21:345-352.
12. Singh P, Peterson TE, Sert-Kuniyoshi FH, Jensen MD, Somers VK. Leptin upregulates caveolin-1 expression: Implications for development of atherosclerosis. Atherosclerosis. 2011;217:499-502.
13. Jiang L, Wang Q, Yu Y, Zhao F, Huang P, Zeng R, Qi RZ, Li W, Liu Y. Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS One. 2009;4:e6884.
14. Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH, Barzilai N. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. Faseb J. 2007;21:53-60. (Pubitemid 46061355)
15. Wang MY, Chen L, Clark GO, Lee Y, Stevens RD, Ilkayeva OR, Wenner BR, Bain JR, Charron MJ, Newgard CB, Unger RH. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci USA. 2010;107: 4813-4819.
16. Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, Hamnvik OP, Koniaris A. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab. 2011;301:E567-E584.